Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump 
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims 
Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips 
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails 
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies 
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations 
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA 
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market 
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings 
Hedge Funds Cut Nvidia, Amazon and Microsoft Stakes as AI Valuation Concerns Rise 
OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report 
Bill Gates Pulls Out of India’s AI Impact Summit Amid Controversy and Event Mismanagement 
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged 
NEW YORK, May 07, 2018 -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference in New York City on Tuesday, May 8th at 3:50 PM, Eastern Time. Interim Chief Executive Officer of Milestone Scientific, Leonard Osser, will be presenting, as well as meeting with investors. Mr. Osser will also be presenting on the Disruptive Injectables & Oncology Panel at 1:45 PM on May 8th.
The 2018 Disruptive Growth & Healthcare Conference will offer investors the opportunity to discover life science companies focusing on solutions for unmet medical needs and growth companies with disruptive technologies and business models.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation instruments, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: [email protected]
Tele: 212-671-1020
